| Financial Year |
March 31 2023 |
| Monetary Funds |
16,695,948,000.00 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
596,700,000.00 |
| Accounts Receivable |
3,245,922,000.00 |
| Advances to Suppliers |
332,611,000.00 |
| Other Receivables |
132,846,000.00 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
5,700,000.00 |
| Inventories |
822,300,000.00 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
9,800,000.00 |
| Other Current Assets |
4,848,659,000.00 |
| Total Current Assets |
27,314,892,000.00 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
67,926,000.00 |
| Long-term Equity Investment |
10,311,050,000.00 |
| Investment Properties |
2,059,316,000.00 |
| Fixed Assetes |
44,141,222,000.00 |
| Under-construction Projects |
10,916,375,000.00 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
9,916,909,000.00 |
| R&D expenses |
-- |
| Goodwill |
321,965,000.00 |
| Long-Term Deferred and Prepaid Expenses |
49,634,000.00 |
| Deferred Income Tax Assets |
1,005,596,000.00 |
| Other Non-Current Assets |
635,336,000.00 |
| Sub-Total of Non-Current Assets |
81,600,190,000.00 |
| Total Assets |
108,915,082,000.00 |
| Short-Term Loans |
952,566,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
2,775,058,000.00 |
| Accounts Received In Advance |
139,554,000.00 |
| Employee Compensation Payable |
297,059,000.00 |
| Taxes Payable |
421,417,000.00 |
| Interest Payable |
92,936,000.00 |
| Dividend Payable |
26,336,000.00 |
| Other payables |
2,903,649,000.00 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
706,129,000.00 |
| Other Current Liabilities |
2,583,000.00 |
| Sub-Total of Current Liabilities |
18,467,317,000.00 |
| Long-term Loans |
7,334,497,000.00 |
| Bonds Payable |
3,310,000,000.00 |
| Long-Term Accounts Payable |
991,055,000.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
20,204,000.00 |
| Deferred Income Tax Liabilities |
436,245,000.00 |
| Other Non-Current Liabilities |
145,537,000.00 |
| Sub-Total of Non-Current Liabilities |
12,854,862,000.00 |
| Total Liabilities |
31,322,179,000.00 |
| Paid-In Capital(Or Share Stock) |
19,454,388,000.00 |
| Capital Surplus |
26,720,619,000.00 |
| Surplus Reserve |
3,326,242,000.00 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
22,586,023,000.00 |
| Minority Stockholder's Interest |
4,626,538,000.00 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
72,966,365,000.00 |
| Owner's Equity（Stockholder's Equity） |
77,592,903,000.00 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
108,915,082,000.00 |
